Bildkälla: Stockfoto

Alzecure: Outcome of rights issue - Redeye

Redeye comments on the outcome of Alzecures oversubscribed rights issue and reiterate our base case for now.

Redeye comments on the outcome of Alzecures oversubscribed rights issue and reiterate our base case for now.
Börsvärldens nyhetsbrev
ANNONSER